You are here

Results for COVID vaccines

Tuesday 23 February 2021

Nuku'alofa, Tonga
Air New Zealand will trial a digital vaccine passport for three weeks starting in April on its Auckland – Sydney route, the airline announced yesterday.
Node is premium Premium content
Thursday 18 February 2021

Canberra, Australia
Australia plans to start the roll out of the Pfizer/BioNTech CoViD-19 vaccine next week to the first and most vulnerable Australians from 22 February.
Node is premium Premium content
Friday 12 February 2021

Auckland, New Zealand
New Zealand expects to vaccinate border workers within two to three weeks, followed by their household contacts, with the first batch of the Pfizer/BioNTech COVID-19 vaccine set to arrive in the country next week, announced Prime Minister Jacinda Ardern today.
Node is premium Premium content
Tuesday 9 February 2021

Nuku'alofa, Tonga
Tonga could receive the CoViD-19 vaccine “maybe at the end of the first quarter or beginning of the second quarter of the year,” the Ministry of Health Acting CEO, Dr Reynold ‘Ofanoa, said today, 9 February. Home quarantine was no longer allowed, because 27 people had breached the rules, out of 1,624 repatriates.
Node is premium Premium content
Saturday 30 January 2021

Nuku'alofa, Tonga
Tonga is finalizing its National Deployment and Vaccination Plans to access CoViD-19 vaccines from the COVAX Facility, and initial quantities are expected to be announced soon. Health CEO, Dr Siale ‘Akau’ola said COVAX is assessing the readiness of participant countries, who will have to make a contribution if they want vaccination coverage of their population to be increased. Meanwhile, some other Pacific countries have started their vaccination programmes.
Node is premium Premium content
Thursday 28 January 2021

Geneva, Switzerland
The World Health Organization (WHO) is calling on all countries to play their part in distributing CoViD-19 vaccines equally.
Node is premium Premium content
Tuesday 26 January 2021

New York, USA
New York Times reporting: Vaccines by Moderna and Pfizer-BioNTech effectively protect recipients. But in a worrying sign, they are slightly less effective against a variant found in South Africa. The news underscored a realization by scientific experts that the virus is changing more quickly than once thought.